Literature DB >> 1639490

Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

R K Gupta1, S C Szu, R A Finkelstein, J B Robbins.   

Abstract

Protection against cholera has been correlated with the level of serum vibriocidal antibodies. The specificity of these vibriocidal antibodies was mostly to the lipopolysaccharide (LPS). We synthesized conjugates of detoxified LPS with cholera toxin (CT) and other proteins in order to elicit serum LPS antibodies with vibriocidal activity. Treatment with hydrazine (deacylated LPS) reduced the endotoxic properties of the LPS to clinically acceptable levels and resulted in a molecule larger and more antigenic than the saccharide produced by acid hydrolysis. More immunogenic conjugates resulted from multipoint compared with single-point attachment of the deacylated LPS to the protein. The conjugates containing CT had low levels of pyrogen and no toxic activity upon Chinese hamster ovary cells and elicited booster responses of vibriocidal and CT antibodies when injected subcutaneously as saline solutions into mice; the vibriocidal titers were similar to those elicited by comparable doses of cellular vaccines. We suggest how serum vibriocidal antibodies might prevent cholera.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639490      PMCID: PMC257302          DOI: 10.1128/iai.60.8.3201-3208.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  SEROLOGICAL RESPONSES IN MAN TO A SINGLE SMALL DOSE OF CHOLERA VACCINE WITH SPECIAL REFERENCE TO THE LACK OF INFLUENCE OF ABO BLOOD GROUP ON NATURAL ANTIBODY OR IMMUNOLOGICAL RESPONSIVENESS.

Authors:  R A FINKELSTEIN; C J POWELL; J C WOODROW; J R KREVANS
Journal:  Bull Johns Hopkins Hosp       Date:  1965-03

2.  Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.

Authors:  M LANDY; S GAINES; J R SEAL; J E WHITSIDE
Journal:  Am J Public Health Nations Health       Date:  1954-12

3.  Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh.

Authors:  D A Sack; J D Clemens; S Huda; J R Harris; M R Khan; J Chakraborty; M Yunus; J Gomes; O Siddique; F Ahmed
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

4.  Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity.

Authors:  W N Burnette; V L Mar; B W Platler; J D Schlotterbeck; M D McGinley; K S Stoney; M F Rohde; H R Kaslow
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Studies on yeast metabolism. I. Fractionation and microdetermination of cell carbohydrates.

Authors:  W E TREVELYAN; J S HARRISON
Journal:  Biochem J       Date:  1952-01       Impact factor: 3.857

6.  Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.

Authors:  P A Manning; M W Heuzenroeder; J Yeadon; D I Leavesley; P R Reeves; D Rowley
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

7.  Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas.

Authors:  A Ahmed; A K Bhattacharjee; W H Mosley
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

8.  Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.

Authors:  J D Clemens; D A Sack; J Chakraborty; M R Rao; F Ahmed; J R Harris; F van Loon; M R Khan; M Yunis; S Huda
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

9.  New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.

Authors:  L Winner; J Mack; R Weltzin; J J Mekalanos; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.

Authors:  C Y Chu; B K Liu; D Watson; S S Szu; D Bryla; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more
  36 in total

1.  Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

Authors:  E Konadu; J Shiloach; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

3.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

4.  Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.

Authors:  Peng Xu; Meagan Kelly; Willie F Vann; Firdausi Qadri; Edward T Ryan; Pavol Kováč
Journal:  Chembiochem       Date:  2017-03-23       Impact factor: 3.164

5.  Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen.

Authors:  E Paulovicová; E Machová; A Hostacká; S Bystrický
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

6.  A scalable method for O-antigen purification applied to various Salmonella serovars.

Authors:  F Micoli; S Rondini; M Gavini; I Pisoni; L Lanzilao; A M Colucci; C Giannelli; F Pippi; L Sollai; V Pinto; F Berti; C A MacLennan; L B Martin; A Saul
Journal:  Anal Biochem       Date:  2012-11-07       Impact factor: 3.365

7.  Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins.

Authors:  X X Gu; C M Tsai; T Ueyama; S J Barenkamp; J B Robbins; D J Lim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

8.  Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Authors:  C C Häse; L S Thai; M Boesman-Finkelstein; V L Mar; W N Burnette; H R Kaslow; L A Stevens; J Moss; R A Finkelstein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

Authors:  R K Gupta; W Egan; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.